Immunohistochemical characterization of endocervical papillary serous carcinoma

International Journal of Gynecological Cancer

Volumn 16, Issue SUPPL. 1, 2006, Pages 286-292

  Nofech Mozes, S ^a   Rasty, G ^a   Ismiil, N ^a   Covens, A ^b   Khalifa, M A ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

CEA; Immunohistochemistry; p53; Papillary serous cervical carcinoma

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; MONOCLONAL ANTIBODY KI 67; PROTEIN BCL 2; PROTEIN P53;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CELL STRUCTURE; CELL TYPE; CLINICAL ARTICLE; COCHRANE LIBRARY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTADENOCARCINOMA; ENDOCERVICAL PAPILLARY SEROUS CARCINOMA; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MANTEL HAENSZEL TEST; MUCINOUS CARCINOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA, PAPILLARY; ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASM STAGING; NEPRILYSIN; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ESTROGEN; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS; WT1 PROTEINS;

EID: 33645369159     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00514.x     Document Type: Article

References (30)

1. Shintaku M Ueda H. Serous papillary adenocarcinoma of the uterine cervix. Histopathology 1993 22 506 7.
2. Young RH Scully RE. Invasive adenocarcinoma and related tumors of the uterine cervix. Semin Diagn Pathol 1990 7 205 27.
3. Lurie S Dgani R Gorbacz S Borenstein R. Invasive papillary serous adenocarcinoma of the endocervix in pregnancy: a case report. Eur J Obstet Gynecol Reprod Biol 1991 40 79 81.
4. Marcus SL Marcus CC. Primary adenocarcinoma of the cervix uteri. Am J Obstet Gynecol 1963 86 384 96.
5. Abell MR Gosling JR. Gland cell carcinoma (adenocarcinoma) of the uterine cervix. Am J Obstet Gynecol 1962 83 729 55.
6. Gilks CB Clement PB. Papillary serous adenocarcinoma of the uterine cervix: a report of three cases. Mod Pathol 1992 5 426 31.
7. Singh N Arif S. Histopathologic parameters of prognosis in cervical cancer - a review. Int J Gynecol Cancer 2004 14 741 50.
8. Zhou C Gilks CB Hayes M Clement PB. Papillary serous carcinoma of the uterine cervix: a clinicopathologic study of 17 cases. Am J Surg Pathol 1998 22 113 20.
9. Costa MJ Hansen C Dickerman A Scudder SA. Clinicopathologic significance of transitional cell carcinoma pattern in nonlocalized ovarian epithelial tumors (stages 2-4). Am J Clin Pathol 1998 109 173 80.
10. Batistatou A Zolota V Tzoracoleftherakis E Scopa CD. Papillary serous adenocarcinoma of the endocervix: a rare neoplasm. Immunohistochemical profile. Int J Gynecol Cancer 2000 10 336 9.
11. Li-Fehmi R Qureshi F Lawrence WD Jacques SM. Apoptosis, proliferation, and expression of p53 and bcl-2 in endocervical glandular intraepithelial lesions and invasive endocervical adenocarcinoma. Int J Gynecol Pathol 2004 23 1 6.
12. McCluggage WG. A critical appraisal of the value of immunohistochemistry in diagnosis of uterine neoplasms. Adv Anat Pathol 2004 11 162 71.
13. Deavers MT Malpica A Silva EG. Immunohistochemistry in gynecological pathology. Int J Gynecol Cancer 2003 13 567 79.
14. Ordi J Romagosa C Tavassoli FA et al. CD10 expression in epithelial tissues and tumors of the gynecologic tract: a useful marker in the diagnosis of mesonephric, trophoblastic, and clear cell tumors. Am J Surg Pathol 2003 27 178 86.
15. McCluggage WG Oliva E Herrington CS McBride H Young RH. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma. Histopathology 2003 43 144 50.
16. Young RH Clement PB. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis. Histopathology 2002 41 185 207.
17. Kaplan EJ Caputo TA Shen PU Sassoon RI Soslow RA. Familial papillary serous carcinoma of the cervix, peritoneum, and ovary: a report of the first case. Gynecol Oncol 1998 70 289 94.
18. Silverberg SG Ioffe OB. Pathology of cervical cancer. Cancer J 2003 9 335 47.
19. Grisaru D Covens A Chapman B et al. Does histology influence prognosis in patients with early-stage cervical carcinoma? Cancer 2001 92 2999 3004.
20. Cina SJ Richardson MS Austin RM Kurman RJ. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix. Mod Pathol 1997 10 176 80.
21. Dabbs DJ Geisinger KR Norris HT. Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns. Am J Surg Pathol 1986 10 568 76.
22. Tjalma W Weyler J Goovaerts G De PC Van ME van DP. Prognostic value of bcl-2 expression in patients with operable carcinoma of the uterine cervix. J Clin Pathol 1997 50 33 6.
23. Leung TW Xue WC Cheung AN Khoo US Ngan HY. Proliferation to apoptosis ratio as a prognostic marker in adenocarcinoma of uterine cervix. Gynecol Oncol 2004 92 866 72.
24. Covens A Rosen B Murphy J et al. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years. Gynecol Oncol 2001 81 133 7.
25. Rose PG Reale F. Case report: Serous papillary carcinoma of the cervix. Gynecol Oncol 1993 50 361 4.
26. Zhou C Matisic JP Clement PB et al. Cytologic features of papillary serous adenocarcinoma of the uterine cervix. Cancer 1997 81 2 98 104.
27. Kayler O Salan A. Cervical serous adenocarcinoma responding neoadjuvant chemotherapy: a case report. Int J Gynecol Cancer 2004 14 Suppl 1 241.
28. Al-Hussaini M Stockman A Foster H et al. WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma. Histopathology 2004 44 109 15.
29. Carcangiu ML Chambers JT Voynick IM et al. Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: clinical and histologic correlations. Am J Clin Pathol 1990 94 247 54.
30. McCluggage WG Sumathi VP McBride HA et al. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas. Int J Gynecol Pathol 2002 21 11 5.